Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP283501.RAk7evdzlzW7U7ycLoIY0o_FY89gi3e1exVeY7pgkEvio130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP283501.RAk7evdzlzW7U7ycLoIY0o_FY89gi3e1exVeY7pgkEvio130_assertion type Assertion NP283501.RAk7evdzlzW7U7ycLoIY0o_FY89gi3e1exVeY7pgkEvio130_head.
- NP283501.RAk7evdzlzW7U7ycLoIY0o_FY89gi3e1exVeY7pgkEvio130_assertion description "[KRAS mutations were frequent in villous (67%) and tubulovillous (60%) adenomas but were rare or absent in tubular adenomas (6%) and serrated lesions, including hyperplastic polyps, sessile serrated polyps/sessile serrated lesions and traditional serrated adenomas (0-9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283501.RAk7evdzlzW7U7ycLoIY0o_FY89gi3e1exVeY7pgkEvio130_provenance.
- NP283501.RAk7evdzlzW7U7ycLoIY0o_FY89gi3e1exVeY7pgkEvio130_assertion evidence source_evidence_literature NP283501.RAk7evdzlzW7U7ycLoIY0o_FY89gi3e1exVeY7pgkEvio130_provenance.
- NP283501.RAk7evdzlzW7U7ycLoIY0o_FY89gi3e1exVeY7pgkEvio130_assertion SIO_000772 22374786 NP283501.RAk7evdzlzW7U7ycLoIY0o_FY89gi3e1exVeY7pgkEvio130_provenance.
- NP283501.RAk7evdzlzW7U7ycLoIY0o_FY89gi3e1exVeY7pgkEvio130_assertion wasDerivedFrom befree-20140225 NP283501.RAk7evdzlzW7U7ycLoIY0o_FY89gi3e1exVeY7pgkEvio130_provenance.
- NP283501.RAk7evdzlzW7U7ycLoIY0o_FY89gi3e1exVeY7pgkEvio130_assertion wasGeneratedBy ECO_0000203 NP283501.RAk7evdzlzW7U7ycLoIY0o_FY89gi3e1exVeY7pgkEvio130_provenance.